Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and methadone don't increase advanced liver disease risk in HCV+ male veterans.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Finasteride is safe for hair loss treatment and doesn't increase high-grade prostate cancer risk.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

Looking older on the outside might be linked to aging faster on the inside and can be affected by lifestyle choices and health risks.

The document concludes that sex hormones and related compounds have various effects on health, with both potential benefits and risks.

Finasteride lowers risk of urinary issues and surgery by over 50% in 4 years.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Breathing in high levels of certain air pollutants significantly increases women's risk of developing Polycystic Ovary Syndrome.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

The Rotterdam Study found risk factors for elderly diseases, links between lifestyle and genetics with health conditions, and aimed to explore new areas like DNA methylation and sensory input effects on brain function.

DHT may increase the risk of heart disease and death in elderly men.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.